Home            Past Issues            About IP            About IAP           Author Information            Subscription            Advertisement              Search  

   
Correspondence

Indian Pediatr 2021;58: 288-289

The Incompleteness of Incomplete Kawasaki Disease: A Customized Definition Is Needed for Indian Children

 

Karthi Nallasamy1* and Winsley Rose2

1Pediatric Emergency and Intensive Care, Advanced Pediatrics Centre, PGIMER, Chandigarh; 2Pediatric Infectious Diseases, Department of Pediatrics, Christian Medical College and Hospital,
Vellore, Tamil Nadu; India.

Email: [email protected]

 


We read with interest the Indian Academy of Pediatrics position paper on Kawasaki disease in the journal [1]. It is indeed timely that this statement has come out amidst the coronavirus disease (COVID-19) pandemic and associated multisystem inflammatory syndrome in children. The authors have aimed to present this paper as a practice guideline specific to resource constrained setting like ours. In this context, we have the following comments:

In describing the definition for incomplete KD, the authors have presented the diagnostic approach, which is largely adapted from American Heart Association (AHA) scientific statement on Kawasaki disease [2]. While AHA algorithm considers evaluation for incomplete KD in children with fever ³5 days and 2 or 3 compatible clinical criteria, the algorithm by Shenoy, et al. [1] triggers KD evaluation if fever ³5 days is accompanied by less than four compatible clinical features. Although these two statements appear similar, this approach loses specificity by including children who present with fever and just one compatible clinical feature. Individually, the clinical features like rash, lymphadenopathy, conjunctival injection, oral or extremity changes are nonspecific and may occur with various childhood infections in India. This approach risks huge number of children with underlying infections being referred for echocardio-graphic evaluation.

Treatment with intravenous immunoglobulin is recommended if 3 of the 5 laboratory features (anemia for age, platelet ³450×109/L, albumin <3 g/dL, elevated alanine aminotransferase, leucocyte count ³15 ×109/L, urine >10 WBC/hpf) are met in a child lacking echocardiographic abnormalities. Compared to Western cohorts, these criteria should be carefully defined in a low- and middle-income setting like India, with a high prevalence of iron deficiency anemia [3] and associated thrombocytosis (present in up to a quarter of those with iron deficiency) [4]. Iron deficiency when associated with infection accounted for more than half of all cases of reactive thrombocytosis in Indian children [5]. Given these findings, the current definition is likely to overestimate the burden of incomplete KD in Indian children, risking increased cost and potentially delaying the diagnosis of underlying infections. For example, as per the algorithm, a child with undifferentiated fever ³5 days due to measles or a rickettsial infection that has a rash, iron deficiency anemia (and associated thrombo-cytosis) and hypoalbuminemia (negative acute phase reactant) would be treated for Kawasaki disease even if the echocardiogram is normal. In the absence of a ‘gold standard’ for diagnosis, we believe that grading recommendations based on available quality of evidence may be more useful for the readers to make informed decisions [6].

REFERENCES

1. Shenoy B, Singh S, Ahmed MZ, et al. Indian Academy of Pediatrics Position Paper on Kawasaki Disease. Indian Pediatr. 2020;57:1040-48.

2. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals from the American Heart Association. Circulation. 2017;135:e 927-99.

3. Onyeneho NG, Ozumba BC, Subramanian SV. Determinants of childhood anemia in India. Sci Rep. 2019; 9:16540.

4. Ray S, Chandra J, Sharma S. Clinico-hematological study of abnormalities of platelet count in children with iron deficiency anemia. International Journal of Contemporary Pediatrics. 2019; 6:1519-23.

5. Subramaniam N, Mundkur S, Kini P, Bhaskaranand N, Aroor S. Clinicohematological study of thrombocytosis in children. ISRN Hematol. 2014;2014:389257.

6. Halperin JL, Levine GN, Al-Khatib SM, et al. Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016;67:1572-74.

 

 

Copyright © 1999-2021 Indian Pediatrics